van Baal P - Search Results

1

Drug Pricing, Patient Welfare, and Cost-Effectiveness Analysis.

van Baal P, Barros PP. van Baal P, et al. Value Health. 2024 Mar;27(3):271-272. doi: 10.1016/j.jval.2024.01.006. Epub 2024 Jan 27. Value Health. 2024. PMID: 38286248 No abstract available.

2

The Value of Health in a Cost-Effectiveness Analysis: Theory Versus Practice.

Wouterse B, van Baal P, Versteegh M, Brouwer W. Wouterse B, et al. Among authors: van baal p. Pharmacoeconomics. 2023 Jun;41(6):607-617. doi: 10.1007/s40273-023-01265-8. Epub 2023 Apr 18. Pharmacoeconomics. 2023. PMID: 37072598 Free PMC article.

3

Future Costs in Cost-Effectiveness Analyses: Past, Present, Future.

de Vries LM, van Baal PHM, Brouwer WBF. de Vries LM, et al. Pharmacoeconomics. 2019 Feb;37(2):119-130. doi: 10.1007/s40273-018-0749-8. Pharmacoeconomics. 2019. PMID: 30474803 Free PMC article.

4

Cured Today, Ill Tomorrow: A Method for Including Future Unrelated Medical Costs in Economic Evaluation in England and Wales.

Perry-Duxbury M, Asaria M, Lomas J, van Baal P. Perry-Duxbury M, et al. Among authors: van baal p. Value Health. 2020 Aug;23(8):1027-1033. doi: 10.1016/j.jval.2020.05.006. Epub 2020 Jul 19. Value Health. 2020. PMID: 32828214 Free article.

5

Practical Guidance for Including Future Costs in Economic Evaluations in The Netherlands: Introducing and Applying PAID 3.0.

Kellerborg K, Perry-Duxbury M, de Vries L, van Baal P. Kellerborg K, et al. Among authors: van baal p. Value Health. 2020 Nov;23(11):1453-1461. doi: 10.1016/j.jval.2020.07.004. Epub 2020 Oct 2. Value Health. 2020. PMID: 33127016 Free article.

6

Quality-Adjusted Life-Years Lost Due to COVID-19 Mortality: Methods and Application for The Netherlands.

Wouterse B, Ram F, van Baal P. Wouterse B, et al. Among authors: van baal p. Value Health. 2022 May;25(5):731-735. doi: 10.1016/j.jval.2021.12.008. Epub 2022 Feb 3. Value Health. 2022. PMID: 35500946 Free PMC article.

7

Informal Care Costs According to Age and Proximity to Death to Support Cost-Effectiveness Analyses.

de Groot S, Santi I, Bakx P, Wouterse B, van Baal P. de Groot S, et al. Among authors: van baal p. Pharmacoeconomics. 2023 Sep;41(9):1137-1149. doi: 10.1007/s40273-022-01233-8. Epub 2023 Feb 1. Pharmacoeconomics. 2023. PMID: 36725787 Free PMC article.

8

The Relevance of Including Future Healthcare Costs in Cost-Effectiveness Threshold Calculations for the UK NHS.

Perry-Duxbury M, Lomas J, Asaria M, van Baal P. Perry-Duxbury M, et al. Among authors: van baal p. Pharmacoeconomics. 2022 Feb;40(2):233-239. doi: 10.1007/s40273-021-01090-x. Epub 2021 Oct 26. Pharmacoeconomics. 2022. PMID: 34697717 Free PMC article.

9

MODELLING HEALTH-RELATED QUALITY OF LIFE (HRQOL) LONGITUDINALLY. A BAYESIAN MIXED BETA REGRESSION APPROACH.

Gheorghe M, Brouwer W, van Baal P. Gheorghe M, et al. Among authors: van baal p. Value Health. 2014 Nov;17(7):A565-6. doi: 10.1016/j.jval.2014.08.1880. Epub 2014 Oct 26. Value Health. 2014. PMID: 27201876 Free article. No abstract available.

10

Estimating Quality of Life Decrements in Oncology Using Time to Death.

Versteegh M, van der Helm I, Mokri H, Oerlemans S, Blommestein H, van Baal P. Versteegh M, et al. Among authors: van der helm i, van baal p. Value Health. 2022 Oct;25(10):1673-1677. doi: 10.1016/j.jval.2022.06.002. Epub 2022 Jul 6. Value Health. 2022. PMID: 35803844 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

97 results

Search Page